IHC - PIN 4

The IHC – PIN4 test is a specialized immunohistochemistry (IHC) diagnostic panel used to evaluate prostate tissue and help diagnose prostate adenocarcinoma. The PIN4 panel combines three important markers: AMACR (P504S), p63, and High Molecular Weight Cytokeratin (HMWCK). Together, these markers help pathologists accurately distinguish cancerous prostate glands from benign prostate tissue.

This test is especially useful when routine microscopic examination of a prostate biopsy is inconclusive. It is commonly used to confirm the diagnosis of prostate cancer, particularly in cases involving small atypical glandular proliferations where distinguishing benign from malignant tissue is challenging.

Each marker in the PIN4 panel provides specific diagnostic information:

• AMACR (P504S): Usually positive in prostate cancer cells
• p63: Highlights basal cells, typically absent in prostate adenocarcinoma
• HMWCK: Detects basal cells present in benign glands but absent in malignant glands

By analyzing these markers together, pathologists can make a highly accurate diagnosis.

Benefits of the Test

The PIN4 IHC test offers several clinical benefits:

• Improves accuracy of prostate cancer diagnosis
• Differentiates benign and malignant prostate glands
• Confirms atypical prostate biopsy findings
• Reduces uncertainty in difficult pathology cases
• Supports tumor classification and grading
• Helps guide personalized treatment planning

This panel is one of the most reliable tools for confirming prostate adenocarcinoma.

Why Doctors Recommend This Test

Doctors recommend the PIN4 IHC test when prostate biopsy results are suspicious or inconclusive.

It is commonly advised for:

• Atypical small acinar proliferation (ASAP) evaluation
• Suspected prostate adenocarcinoma
• Difficult prostate biopsy interpretation
• Confirmation of malignant glandular lesions
• Advanced pathology review of prostate tumors

The results help urologists and oncologists make informed treatment decisions.

Preparation Before Test

No special preparation is required from the patient. The test is performed on previously collected prostate biopsy or surgical tissue specimens.

Normal Reporting Time

The typical turnaround time for the PIN4 IHC test is 2 to 4 working days, depending on laboratory processing and tissue complexity.

Who Should Take This Test

This test is recommended for:

• Patients with suspicious prostate biopsy findings
• Individuals with suspected prostate cancer
• Patients needing confirmation of prostate adenocarcinoma
• Cases requiring detailed tissue classification
• Oncology patients undergoing prostate pathology evaluation

The IHC PIN4 test is an essential diagnostic tool in modern prostate pathology. It improves diagnostic precision, confirms malignant glandular changes, and supports early treatment planning for better patient outcomes.